33 results
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
Review Elagolix ... the FDA for the treatment ... #Pharmacology #Elagolix ... #Orilissa #Review ... #Overview
Lidocaine HCl - sodium channel blocker. Local anesthetic and class 1B antiarrhythmic. Originally developed in 1943
Lidocaine HCl - ... #Pharmacology #Lidocaine ... Xylocaine #Systemic #Review ... #Overview
Alprazolam - short-acting benzodiazepine (GABA Receptor Modulator) used in the treatment of anxiety disorders. FDA approved
Modulator) used in the treatment ... #Pharmacology #Alprazolam ... #Xanax #Overview ... #Review
Metformin - oral antihyperglycemic agent for treatement of type II diabetes. 8th most prescribed drug in
antihyperglycemic agent for treatement ... #Pharmacology #Metformin ... Fortamet #AMPK #Overview ... #Review
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
An overview of high ... #pharmacology #overview ... #review #dosing ... comparison #drugs #table
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Amlodipine - calcium channel blocker for the treatment of hypertension and CAD. 5th most prescribed drug
blocker for the treatment ... #Pharmacology #Amlodipine ... CalciumChannelBlocker #CCB #Overview ... #Review
Lisinopril - ACE inhibitor used for the treatment of hypertension and heart failure. 3rd most prescribed
inhibitor used for the treatment ... #Pharmacology #Lisinopril ... AngiotensinConvertingEnzyme #Inhibitor #Overview ... #Review
REBEL Review 71: Treatment of Thyroid Storm 

Propranolol 
Esmolol 
Propylthiouracil (PTU) 
Methimazole 
Saturated Solution of Potassium
REBEL Review 71: ... Treatment of Thyroid ... hyperthyroidism #table ... #management #treatment ... #pharmacology #
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology